(Q46616178)

23 December 2017

title

A urinary test for pulmonary arterial hypertension? (English)

1 reference

23 December 2017

author name string

Abigail R Lara

series ordinal

1

1 reference

23 December 2017

Serpil C Erzurum

series ordinal

2

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

23 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

23 December 2017

volume

172

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

262-263

1 reference

23 December 2017

The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2505009

Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2505009

Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2505009

High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2505009

Oxidative stress in severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2505009

Nitric oxide and pulmonary arterial pressures in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2505009

Nitrate biosynthesis in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2505009

Decreased whole body endogenous nitric oxide production in patients with primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2505009

Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2505009

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2505009

Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2505009

21 January 2018

Identifiers

DOI

10.1164/RCCM.2505009

1 reference

23 December 2017

1 reference

23 December 2017